3P Land Holdings Limited
The Exchange has sought clarification from 3P Land Holdings Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
Andhra Cements Limited
The Exchange has sought clarification from Andhra Cements Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
Adani Green Energy Limited
The Exchange has sought clarification from Adani Green Energy Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
Advani Hotels & Resorts (India) Lim
Advani Hotels & Resorts (India) Limited has submitted the Exchange a copy of Srutinizer's Report on Postal Ballot Result.
Affle 3i Limited
Affle 3i Limited has informed the Exchange regarding 'Allotment of shares to Company's ESOP Trust'.
AGS Transact Technologies Limited
AGS Transact Technologies Limited has informed the Exchange about Corporate Insolvency Resolution Process
Ajanta Pharma Limited
Ajanta Pharma Limited has informed the Exchange about Schedule of meet
The Anup Engineering Limited
The Exchange has sought clarification from The Anup Engineering Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 12, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for BosutinibTablets, 400 mg".
Aptech Limited
The Exchange has sought clarification from Aptech Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
